SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3m1r'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 12 ILE A  61
ALA A 301
LEU A 267
ILE A 239
THR A 298
None
1.07A 2bl9A-3m1rA:
undetectable
2bl9A-3m1rA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OBV_A_SAMA501_0
(S-ADENOSYLMETHIONINE
SYNTHETASE ISOFORM
TYPE-1)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.13A 2obvA-3m1rA:
undetectable
2obvA-3m1rA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2P02_A_SAMA2_0
(S-ADENOSYLMETHIONINE
SYNTHETASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.07A 2p02A-3m1rA:
undetectable
2p02A-3m1rA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_A_TOPA1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 11 ILE A  61
ALA A 301
LEU A 268
ILE A 285
THR A 298
None
1.03A 2w9sA-3m1rA:
undetectable
2w9sA-3m1rA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_C_TOPC1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 10 ILE A  61
ALA A 301
LEU A 268
ILE A 285
THR A 298
None
0.97A 2w9sC-3m1rA:
undetectable
2w9sC-3m1rA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9S_E_TOPE1160_1
(DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 ILE A  61
ALA A 301
ILE A 285
THR A 298
None
0.78A 2w9sE-3m1rA:
undetectable
2w9sE-3m1rA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EL9_A_DR7A100_2
(PROTEASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 10 ASP A 289
GLY A  53
ALA A  54
GLY A  59
THR A 298
CL  A 321 ( 4.6A)
CL  A 321 ( 4.4A)
None
PEG  A 324 (-3.4A)
None
1.07A 3el9B-3m1rA:
undetectable
3el9B-3m1rA:
15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GGU_B_017B201_2
(PROTEASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 9 ASP A 289
GLY A  53
ALA A  54
GLY A  59
THR A 298
CL  A 321 ( 4.6A)
CL  A 321 ( 4.4A)
None
PEG  A 324 (-3.4A)
None
1.02A 3gguB-3m1rA:
undetectable
3gguB-3m1rA:
16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW2_A_ADNA300_1
(PROBABLE R-RNA
METHYLTRANSFERASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 11 ILE A 283
GLY A 282
LEU A 306
LEU A 310
ALA A 309
None
1.21A 3kw2A-3m1rA:
2.2
3kw2A-3m1rA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW2_B_ADNB300_1
(PROBABLE R-RNA
METHYLTRANSFERASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 11 ILE A 283
GLY A 282
LEU A 306
LEU A 310
ALA A 309
None
1.20A 3kw2B-3m1rA:
2.5
3kw2B-3m1rA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L2U_A_ELVA397_1
(INTEGRASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 5 ASP A 242
ASP A 244
PRO A 255
GLU A 287
CA  A 322 ( 2.9A)
CA  A 322 (-2.1A)
None
CL  A 320 ( 4.5A)
1.24A 3l2uA-3m1rA:
0.0
3l2uA-3m1rA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L2W_A_ELVA397_1
(INTEGRASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 5 ASP A 242
ASP A 244
PRO A 255
GLU A 287
CA  A 322 ( 2.9A)
CA  A 322 (-2.1A)
None
CL  A 320 ( 4.5A)
1.29A 3l2wA-3m1rA:
1.2
3l2wA-3m1rA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OEZ_A_STIA601_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 5 VAL A 288
ILE A 257
MET A 211
ARG A 300
None
1.33A 3oezA-3m1rA:
0.0
3oezA-3m1rA:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3M_A_DLUA398_1
(PFV INTEGRASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 ASP A 150
ASP A 154
GLY A 166
TYR A 197
CA  A 323 ( 2.7A)
CA  A 323 ( 2.5A)
None
None
1.04A 3s3mA-3m1rA:
undetectable
3s3mA-3m1rA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3N_A_DLUA398_1
(PFV INTEGRASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 ASP A 150
ASP A 154
GLY A 166
TYR A 197
CA  A 323 ( 2.7A)
CA  A 323 ( 2.5A)
None
None
1.02A 3s3nA-3m1rA:
undetectable
3s3nA-3m1rA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UM5_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 10 ILE A 239
VAL A 305
PHE A 149
ILE A 220
ILE A 274
None
1.33A 3um5B-3m1rA:
undetectable
3um5B-3m1rA:
18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_B_0LIB1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 9 LEU A 307
ILE A  34
LEU A  87
ILE A  40
ILE A 122
None
1.01A 3zosB-3m1rA:
undetectable
3zosB-3m1rA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AX8_A_SAMA1474_0
(WBDD)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
6 / 12 GLY A 124
ALA A  54
ILE A 285
ILE A 122
VAL A  42
ILE A  40
None
1.41A 4ax8A-3m1rA:
5.1
4ax8A-3m1rA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AZT_A_SAMA1472_0
(METHYLTRANSFERASE
WBDD)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
6 / 12 GLY A 124
ALA A  54
ILE A 122
LEU A  44
VAL A  42
ILE A  40
None
1.36A 4aztA-3m1rA:
undetectable
4aztA-3m1rA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM4_A_8PRA603_1
(TRANSPORTER)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 12 VAL A 288
ALA A  54
GLY A 124
ASP A 293
THR A 298
None
1.37A 4mm4A-3m1rA:
undetectable
4mm4A-3m1rA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_2
(PROTEASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 10 ASP A 289
GLY A  53
ALA A  54
GLY A  59
THR A 298
CL  A 321 ( 4.6A)
CL  A 321 ( 4.4A)
None
PEG  A 324 (-3.4A)
None
1.03A 4njtB-3m1rA:
undetectable
4njtB-3m1rA:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODJ_A_SAMA500_0
(S-ADENOSYLMETHIONINE
SYNTHASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 7 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.07A 4odjA-3m1rA:
undetectable
4odjA-3m1rA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RZV_B_032B801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 5 PHE A 149
SER A 132
HIS A 101
ASP A 154
None
None
None
CA  A 323 ( 2.5A)
1.32A 4rzvB-3m1rA:
undetectable
4rzvB-3m1rA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UW0_A_SAMA1506_0
(WBDD)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
6 / 12 GLY A 124
ALA A  57
ILE A 122
LEU A  44
VAL A  42
ILE A  40
None
1.30A 4uw0A-3m1rA:
2.1
4uw0A-3m1rA:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A1I_A_ADNA407_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.05A 5a1iA-3m1rA:
undetectable
5a1iA-3m1rA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A1I_A_SAMA405_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 7 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.05A 5a1iA-3m1rA:
undetectable
5a1iA-3m1rA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OS7_A_ACTA402_0
(CASEIN KINASE II
SUBUNIT ALPHA)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
3 / 3 HIS A  67
SER A  23
LYS A  21
None
1.31A 5os7A-3m1rA:
undetectable
5os7A-3m1rA:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE8_A_08JA602_1
(CYTOCHROME P450 3A4)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 7 SER A  68
LEU A 307
ALA A 303
LEU A 268
None
1.05A 5te8A-3m1rA:
undetectable
5te8A-3m1rA:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA402_0
(CYCLIN-G-ASSOCIATED
KINASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 11 ALA A 256
ASP A 126
VAL A 305
ILE A 285
ILE A  61
None
1.35A 5y80A-3m1rA:
undetectable
5y80A-3m1rA:
13.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C2M_C_SUEC1203_1
(NS3 PROTEASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 9 VAL A 206
HIS A 204
GLY A 180
ILE A 239
ASP A 150
None
None
None
None
CA  A 323 ( 2.7A)
1.35A 6c2mC-3m1rA:
undetectable
6c2mC-3m1rA:
14.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C71_B_NCTB501_1
(AMINE OXIDASE)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 LEU A 292
GLU A 287
THR A 291
ASN A 165
None
CL  A 320 ( 4.5A)
CL  A 321 (-3.3A)
CL  A 320 ( 4.7A)
1.14A 6c71B-3m1rA:
undetectable
6c71B-3m1rA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBN_B_SAMB401_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.06A 6fbnB-3m1rA:
undetectable
6fbnB-3m1rA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBO_A_ADNA406_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.10A 6fboA-3m1rA:
undetectable
6fboA-3m1rA:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FCD_A_ADNA405_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 8 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.07A 6fcdA-3m1rA:
undetectable
6fcdA-3m1rA:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G6R_A_SAMA406_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
4 / 7 HIS A 152
ASP A 154
SER A  47
ASP A 242
CA  A 322 (-3.4A)
CA  A 323 ( 2.5A)
None
CA  A 322 ( 2.9A)
1.05A 6g6rA-3m1rA:
undetectable
6g6rA-3m1rA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GMD_B_ACTB402_0
(CASEIN KINASE II
SUBUNIT ALPHA)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
3 / 3 HIS A  67
SER A  23
LYS A  21
None
1.31A 6gmdB-3m1rA:
undetectable
6gmdB-3m1rA:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HLP_A_GAWA1501_0
(SUBSTANCE-P
RECEPTOR,SUBSTANCE-P
RECEPTOR)
3m1r FORMIMIDOYLGLUTAMASE
(Bacillus
subtilis)
5 / 12 ILE A 134
ILE A 177
VAL A 146
ILE A 178
PHE A 236
None
1.09A 6hlpA-3m1rA:
3.6
6hlpA-3m1rA:
19.35